Report: EU Country Cancer Profile 2023 (The Netherlands): Difference between revisions
From Beacon
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
'''Sponsor, manager or home institution:''' [[dataOwner::OECD and European Commission]]. | '''Sponsor, manager or home institution:''' [[dataOwner::OECD and European Commission]]. | ||
'''Type of information:''' National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care. [https://www.oecd-ilibrary.org/social-issues-migration-health/landenprofiel-voor-kanker-nederland-2023_63930e3b-nl Click here to learn more]. | '''Type of information:''' [[hasVariable::cancer incidence]], [[hasVariable::risk of cancer]], [[hasVariable::screening]]. National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care. [https://www.oecd-ilibrary.org/social-issues-migration-health/landenprofiel-voor-kanker-nederland-2023_63930e3b-nl Click here to learn more]. | ||
'''Data level''': [[dataLevel::national level]]. | '''Data level''': [[dataLevel::national level]]. | ||
Revision as of 21:24, 13 June 2024
Go back to The Netherlands page
Primary purpose: To provide reliable data on cancer prevention and care, identifying trends, disparities, and inequalities among EU Member States and regions to guide interventions under Europe's Beating Cancer Plan.
Sponsor, manager or home institution: OECD and European Commission.
Type of information: cancer incidence, risk of cancer, screening. National cancer burden; Cancer incidence and mortality; Risk factors for cancer; Early detection programs (screenings); Cancer care performance, The impact of COVID-19 on cancer care. Click here to learn more.
Data level: national level.
Cancer Areas of Interest: C00-D48: All neoplasms. Click here to learn more.
Access to information: Click here to access.
